Cargando…
Cytokines in Cancer Immunotherapy
Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763400/ https://www.ncbi.nlm.nih.gov/pubmed/24213115 http://dx.doi.org/10.3390/cancers3043856 |
_version_ | 1782283008205651968 |
---|---|
author | Lee, Sylvia Margolin, Kim |
author_facet | Lee, Sylvia Margolin, Kim |
author_sort | Lee, Sylvia |
collection | PubMed |
description | Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines. |
format | Online Article Text |
id | pubmed-3763400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-37634002013-09-05 Cytokines in Cancer Immunotherapy Lee, Sylvia Margolin, Kim Cancers (Basel) Review Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another to generate a coordinated, robust, but self-limited response to a target antigen. The growing interest over the past two decades in harnessing the immune system to eradicate cancer has been accompanied by heightened efforts to characterize cytokines and exploit their vast signaling networks to develop cancer treatments. The goal of this paper is to review the major cytokines involved in cancer immunotherapy and discuss their basic biology and clinical applications. The paper will also describe new cytokines in pre-clinical development, combinations of biological agents, novel delivery mechanisms, and potential directions for future investigation using cytokines. Molecular Diversity Preservation International (MDPI) 2011-10-13 /pmc/articles/PMC3763400/ /pubmed/24213115 http://dx.doi.org/10.3390/cancers3043856 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/) |
spellingShingle | Review Lee, Sylvia Margolin, Kim Cytokines in Cancer Immunotherapy |
title | Cytokines in Cancer Immunotherapy |
title_full | Cytokines in Cancer Immunotherapy |
title_fullStr | Cytokines in Cancer Immunotherapy |
title_full_unstemmed | Cytokines in Cancer Immunotherapy |
title_short | Cytokines in Cancer Immunotherapy |
title_sort | cytokines in cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763400/ https://www.ncbi.nlm.nih.gov/pubmed/24213115 http://dx.doi.org/10.3390/cancers3043856 |
work_keys_str_mv | AT leesylvia cytokinesincancerimmunotherapy AT margolinkim cytokinesincancerimmunotherapy |